A T-Cell-Derived 3-Gene Signature Distinguishes SARS-CoV-2 from Common Respiratory Viruses

Yang Li,Xinya Tao,Sheng Ye,Qianchen Tai,Yu-Ang You,Xinting Huang,Mifang Liang,Kai Wang,Haiyan Wen,Chong You,Yan Zhang,Xiaohua Zhou

DOI: https://doi.org/10.3390/v16071029

2024-06-27

Viruses

Abstract:Research on the host responses to respiratory viruses could help develop effective interventions and therapies against the current and future pandemics from the host perspective. To explore the pathogenesis that distinguishes SARS-CoV-2 infections from other respiratory viruses, we performed a multi-cohort analysis with integrated bioinformatics and machine learning. We collected 3730 blood samples from both asymptomatic and symptomatic individuals infected with SARS-CoV-2, seasonal human coronavirus (sHCoVs), influenza virus (IFV), respiratory syncytial virus (RSV), or human rhinovirus (HRV) across 15 cohorts. First, we identified an enhanced cellular immune response but limited interferon activities in SARS-CoV-2 infection, especially in asymptomatic cases. Second, we identified a SARS-CoV-2-specific 3-gene signature (CLSPN, RBBP6, CCDC91) that was predominantly expressed by T cells, could distinguish SARS-CoV-2 infection, including Omicron, from other common respiratory viruses regardless of symptoms, and was predictive of SARS-CoV-2 infection before detectable viral RNA on RT-PCR testing in a longitude follow-up study. Thereafter, a user-friendly online tool, based on datasets collected here, was developed for querying a gene of interest across multiple viral infections. Our results not only identify a unique host response to the viral pathogenesis in SARS-CoV-2 but also provide insights into developing effective tools against viral pandemics from the host perspective.

virology

What problem does this paper attempt to address?

The main objective of this paper is to identify a host response characteristic that can distinguish between SARS-CoV-2 infection and other common respiratory virus infections (such as seasonal coronaviruses [sHCoVs], influenza virus [IFV], respiratory syncytial virus [RSV], and human rhinovirus [HRV]).

To achieve this goal, the research team conducted a multi-cohort analysis, combining bioinformatics and machine learning methods. They collected a total of 3,730 blood samples from 15 different cohorts, including asymptomatic and symptomatic SARS-CoV-2 infected individuals, other respiratory virus-infected individuals, and healthy controls. Through comprehensive analysis, the researchers found that during SARS-CoV-2 infection, the host cell immune response is enhanced but interferon activity is limited, especially in asymptomatic cases.

The core contribution of the paper is the identification of a SARS-CoV-2-specific gene signature composed of three genes (CLSPN, RBBP6, and CCDC91), which are primarily expressed in T cells. This three-gene signature not only effectively distinguishes SARS-CoV-2 infection (including the Omicron variant) from other common respiratory virus infections but also predicts SARS-CoV-2 infection before RT-PCR detects viral RNA. Additionally, a user-friendly online tool was developed based on the study's dataset, which can be used to query the expression of specific genes in various viral infections.

In summary, this study not only reveals the unique host response mechanism of SARS-CoV-2 but also provides important insights for developing effective tools to combat viral pandemics from the host perspective.